核子医学扫描术诊断设备市场规模、份额和成长分析（按技术、产品类型、应用、最终用户和地区划分）—2026-2033年产业预测

全球核子医学扫描术诊断设备市场规模预计在 2024 年达到 24.7 亿美元，从 2025 年的 26.6 亿美元成长到 2033 年的 47.4 亿美元，在预测期（2026-2033 年）内复合年增长率为 7.5%。

全球核子医学扫描术诊断市场持续稳定扩张，这主要得益于医学影像技术的进步、慢性病盛行率的上升以及对非侵入性诊断方法日益增长的需求。人口老化加剧了老龄化相关疾病的易感性，同时核子医学扫描术诊断在肿瘤学、心臟病学和神经病学领域的应用不断拓展，也进一步推动了这一增长。 PET或SPECT与CT结合的混合影像系统的出现，透过整合解剖和功能讯息，显着提升了诊断能力。此外，人工智慧（AI）和机器学习的应用也显着提高了诊断的准确性和效率。儘管高成本和有限的报销管道等挑战依然存在，但医疗创新、地理扩张和策略合作仍蕴藏着巨大的机会。

推动全球核子医学扫描术诊断设备市场发展的因素

全球核子医学影像市场的发展主要得益于混合系统和分子影像等先进成像技术的涌现。这些技术显着提高了诊断的准确性和效率，使医疗专业人员能够全面了解各种器官和组织的功能，最终有助于改善患者的治疗效果。此外，将人工智慧 (AI) 和机器学习演算法融入这些影像系统，进一步提升了影像品质和诊断潜力。因此，这些发展彻底改变了核子医学扫描术诊断领域，使其成为现代医疗实践和患者照护的关键组成部分。

全球核子医学扫描术诊断设备市场面临的限制因素

全球核子医学扫描术诊断设备市场面临许多挑战，主要原因是这些设备需要大量的资金投入，包括资本支出、安装和持续维护。高成本构成了一大障碍，尤其是在医疗预算有限的发展中地区。此外，成像过程中使用的放射性同位素的相关费用也加重了整体经济负担。这种高昂的价格结构会阻碍市场准入，并限制核医影像技术的广泛应用，尤其是在资源有限的医疗机构中。解决这些成本问题并探索更经济的解决方案对于推动市场成长至关重要。

核子医学扫描术诊断设备市场的全球趋势

全球核子医学扫描术诊断市场的一个显着趋势是混合影像系统的应用，这类系统整合了多种影像模式，例如PET和SPECT与CT和MRI。这种融合技术能够在一次检查中同时提供解剖和功能讯息，从而增强诊断能力。随着医疗专业人员对疾病特征分析和治疗方案製定的日益重视，这些技术的整合有望提升患者照护水准。此外，能够准确识别异常并评估其代谢活性（同时考虑邻近组织）的能力正在推动市场需求，进而促进技术进步和市场成长。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管环境
• 案例研究
• 技术进步

全球核子医学扫描术诊断设备市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 单光子发射电脑断层扫描（SPECT）
• 正子断层扫描（PET）

全球核子医学扫描术诊断设备市场规模（依产品类型及复合年增长率划分）（2026-2033 年）

• PET设备
  • 独立式PET
  • PET/CT
  • PET/MRI
• SPECT设备
  • 独立式SPECT
  • SPECT/CT
  • SPECT/MRI
• 平面成像装置

全球核子医学扫描术诊断设备市场规模（依应用领域划分）及复合年增长率（2026-2033 年）

• 肿瘤学
• 心臟病学
• 神经病学
• 其他的

全球核子医学扫描术诊断设备市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院
• 诊断影像中心
• 学术研究机构
• 其他的

全球核子医学扫描术诊断设备市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• GE HealthCare Technologies（United States）
• Siemens Healthineers（Germany）
• Philips Healthcare（Netherlands）
• Canon Medical Systems Corporation（Japan）
• Neusoft Medical Systems Co., Ltd.（China）
• Mediso Ltd.（Hungary）
• Digirad Corporation（United States）
• CMR Naviscan Corporation（United States）
• Shimadzu Corporation（Japan）
• PerkinElmer（United States）
• MILabs BV（Netherlands）
• MR Solutions Ltd.（United Kingdom）
• SurgicEye GmbH（Germany）
• Triad Isotopes（United States）
• Cardinal Health（United States）
• Lantheus Holdings（United States）
• Medtronic（United States）
• Bayer（Germany）
• SHINE Technologies（United States）

结论与建议

Global Nuclear Imaging Devices Market size was valued at USD 2.47 Billion in 2024 and is poised to grow from USD 2.66 Billion in 2025 to USD 4.74 Billion by 2033, growing at a CAGR of 7.5% during the forecast period (2026-2033).

The global nuclear imaging devices market is experiencing robust expansion fueled by advancements in medical imaging technologies, a rising prevalence of chronic conditions, and an increasing demand for non-invasive diagnostic methods. This growth is further propelled by the aging population, which is more susceptible to age-related illnesses, and the broader applications of nuclear imaging in oncology, cardiology, and neurology. The emergence of hybrid imaging systems that integrate PET or SPECT with CT is enhancing diagnostic capabilities by delivering combined anatomical and functional insights. Furthermore, the incorporation of artificial intelligence and machine learning significantly boosts accuracy and efficiency. Although challenges such as high costs and limited reimbursement options persist, there are substantial opportunities for innovation, geographic expansion, and strategic alliances within the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nuclear Imaging Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nuclear Imaging Devices Market Segments Analysis

Global Nuclear Imaging Devices Market is segmented by Technology, Product Type, Application, End User and region. Based on Technology, the market is segmented into Single-Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET). Based on Product Type, the market is segmented into PET Devices, SPECT Devices and Planar Imaging Devices. Based on Application, the market is segmented into Oncology, Cardiology, Neurology and Others. Based on End User, the market is segmented into Hospitals, Imaging Centers, Academic and Research Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nuclear Imaging Devices Market

The Global Nuclear Imaging Devices market is driven by the emergence of cutting-edge imaging technologies, including hybrid systems and molecular imaging, which significantly improve the accuracy and efficiency of diagnostics. These innovations empower healthcare practitioners to gather comprehensive insights into the functioning of various organs and tissues, thereby enhancing patient outcomes. Moreover, the incorporation of artificial intelligence and machine learning algorithms into these imaging devices further elevates image quality and diagnostic potential. As a result, these developments are transforming the landscape of nuclear imaging, making it a crucial component in modern medical practice and patient care.

Restraints in the Global Nuclear Imaging Devices Market

The Global Nuclear Imaging Devices market faces notable challenges primarily due to the substantial financial investment required for capital expenditures, installation, and continuous maintenance of these devices. The elevated costs present obstacles, particularly in developing regions where healthcare budgets are constrained. Furthermore, the expense associated with radioactive isotopes utilized in imaging procedures compounds the overall financial burden. This high pricing structure can deter market entry and restrict the widespread adoption of nuclear imaging technologies, especially in healthcare facilities grappling with limited resources. To facilitate market growth, it is crucial to address these cost-related issues and explore more affordable solutions.

Market Trends of the Global Nuclear Imaging Devices Market

The Global Nuclear Imaging Devices market is witnessing a significant trend toward the adoption of hybrid imaging systems, which integrate various imaging modalities such as PET and SPECT with CT or MRI. This convergence enhances diagnostic capabilities by providing both anatomical and functional insights in a single examination. As healthcare professionals increasingly seek improved disease characterization and treatment planning, the integration of these technologies is poised to elevate patient care standards. Additionally, the ability to accurately locate abnormalities and assess their metabolic activity while considering adjacent tissues is driving demand, thereby fueling advancements and growth within the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Nuclear Imaging Devices Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Single-Photon Emission Computed Tomography (SPECT)
• Positron Emission Tomography (PET)

Global Nuclear Imaging Devices Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• PET Devices
  • Standalone PET
  • PET/CT
  • PET/MRI
• SPECT Devices
  • Standalone SPECT
  • SPECT/CT
  • SPECT/MRI
• Planar Imaging Devices

Global Nuclear Imaging Devices Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oncology
• Cardiology
• Neurology
• Others

Global Nuclear Imaging Devices Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Imaging Centers
• Academic and Research Centers
• Others

Global Nuclear Imaging Devices Market Size & CAGR (2026-2033)

• North America (Technology, Product Type, Application, End User)
  • US
  • Canada
• Europe (Technology, Product Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Technology, Product Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Technology, Product Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Technology, Product Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• GE HealthCare Technologies (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neusoft Medical Systems Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Ltd. (Hungary)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Digirad Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CMR Naviscan Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MILabs B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MR Solutions Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SurgicEye GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Triad Isotopes (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Holdings (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SHINE Technologies (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations